-
公开(公告)号:US20240174986A1
公开(公告)日:2024-05-30
申请号:US18284793
申请日:2022-03-28
发明人: Agustin FERNANDEZ , Edward GERSHBURG , Paul PREDKI
IPC分类号: C12N7/00 , A61K39/00 , A61K39/245 , A61P31/22 , C07K14/005
CPC分类号: C12N7/00 , A61K39/245 , A61P31/22 , C07K14/005 , A61K2039/522 , C12N2710/16621 , C12N2710/16622 , C12N2710/16634
摘要: Compositions and methods related to a mutant herpesvirus and a mutant ICP0 protein. Vaccine compositions comprising the mutant herpesvirus and/or mutant ICP0 protein. Methods of treatment using the mutant herpesvirus and/or mutant ICP0 protein.
-
公开(公告)号:US20230358746A1
公开(公告)日:2023-11-09
申请号:US18030154
申请日:2021-10-06
发明人: Agustin FERNANDEZ , Edward GERSHBURG , Paul PREDKI
IPC分类号: G01N33/569 , G01N33/58 , G01N21/64
CPC分类号: G01N33/56983 , G01N33/582 , G01N21/6428 , G01N2333/165 , G01N2469/20 , G01N2021/6439
摘要: The disclosure provides an assay for detecting if a subject is seropositive for SARS-CoV-2, or not, comprising incubating a biological sample from the subject with uninfected cells and SARS-CoV-2-infected cells, where the uninfected cells and the SARS-CoV-2-infected cells are distinguishable from each other, to form an admixture, and determining an amount of antibodies in the biological sample bound to the uninfected cells and to the SARS-CoV-2-infected cells, thereby determining whether the subject whose biological sample was tested is seropositive for SARS-CoV-2, or not.
-